menu
    • menu

    Company profile for Telix Pharmaceuticals

    NEW Drugs in Dev: 20
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Telix Pharmaceuticals Limited is a clinical-stage biotechnology company dedicated to developing a pipeline of advanced "theranostic"​ (diagnostic+therapeutic) assets for a number of unmet needs in cancer care. We are headquartered in Melbourne, Australia but our team is international. Telix is an unlisted public company. In December 2018, Telix acquired ANMI SA, a leader in the field of radiopharmaceutical development. The A...
    Telix Pharmaceuticals Limited is a clinical-stage biotechnology company dedicated to developing a pipeline of advanced "theranostic"​ (diagnostic+therapeutic) assets for a number of unmet needs in cancer care. We are headquartered in Melbourne, Australia but our team is international. Telix is an unlisted public company. In December 2018, Telix acquired ANMI SA, a leader in the field of radiopharmaceutical development. The ANMI team brings a wealth of innovation and experience in the streamlined development and production of novel radiopharmaceuticals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Telix PharmaceuticalsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Suite 401 55 Flemington Road, North Melbourne, VIC Australia, 3051
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://telixpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/telixpharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/TelixPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Company Reports Strong Commercial Growth & Focused Pipeline
    Company Reports Strong Commercial Growth & Focused Pipeline

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/20/3241642/0/en/FY-2025-Results-Strong-Commercial-Growth-Focused-Pipeline-Investment.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Telix 2025 Full-Year Results Investor Webcast Notification
    Telix 2025 Full-Year Results Investor Webcast Notification

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3231647/0/en/Telix-Full-Year-Results-2025-Investor-Webcast-Notification.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Telix Hits FY25 Targets: $804M Revenue, Gozellix Launch
    Telix Hits FY25 Targets: $804M Revenue, Gozellix Launch

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221560/0/en/Telix-Achieves-FY-2025-Guidance-with-US-804M-A-1-2B-Revenue-Accelerates-Growth-with-Gozellix-Launch.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    First U.S. Patient Dosed In BiPASS Phase 3 Prostate Cancer Study
    First U.S. Patient Dosed In BiPASS Phase 3 Prostate Cancer Study

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220521/0/en/First-U-S-Patient-Dosed-in-BiPASS-Phase-3-Prostate-Cancer-Diagnosis-Study.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Telix To Showcase Pipeline & Commercial Portfolio At Morgan Conf
    Telix To Showcase Pipeline & Commercial Portfolio At Morgan Conf

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215148/0/en/Telix-to-Present-Pipeline-and-Commercial-Portfolio-Overview-at-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Telix, Varian Announce Theranostics-EBRT Clinical Collaboration
    Telix, Varian Announce Theranostics-EBRT Clinical Collaboration

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203044/0/en/Telix-and-Varian-Announce-Strategic-Theranostics-EBRT-Clinical-Collaboration.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Telix Pharmaceuticals and get a quotation

    Telix Pharmaceuticals is a supplier offers 4 products (APIs, Excipients or Intermediates).

    Find a price of Gallium Chloride bulk with DMF offered by Telix Pharmaceuticals

    Find a price of Zirconium-89 bulk with DMF offered by Telix Pharmaceuticals

    Find a price of [131I]-L-4-IODOPHENYLALANINE (131I-IPA) INJECTION bulk with DMF offered by Telix Pharmaceuticals

    Find a price of KIT FOR THE PREPARATION OF GA-68 PSMA-11 INJECTION bulk offered by Telix Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search